Ontology highlight
ABSTRACT:
SUBMITTER: Hashem Boroojerdi M
PROVIDER: S-EPMC7549730 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
Hashem Boroojerdi Mohadese M Rahbarizadeh Fatemeh F Safarzadeh Kozani Pouya P Kamali Elahe E Safarzadeh Kozani Pooria P
Medical oncology (Northwood, London, England) 20201012 11
In the recent years, using genetically modified T cells has been known as a rapid developing therapeutic approach due to the heartwarming results of clinical trials with patients suffering from relapsed or refractory (R/R) hematologic malignancies such as R/R Acute Lymphoblastic Leukemia (R/R ALL). One of these renowned approaches is Chimeric antigen receptors (CARs). CARs are synthetic receptors with the ability to be expressed on the surface of T lymphocytes and are specifically designed to ta ...[more]